
Broad-Based Technical Strength Lifts Gayatri BioOrganics Ltd to 52-Week High of Rs 20
2026-05-06 09:43:45Surging from a 52-week low of Rs 6.13 to a fresh high of Rs 20, Gayatri BioOrganics Ltd has delivered an impressive 182.45% return over the past year, significantly outperforming the Sensex which declined by 4.09% during the same period. This milestone reflects a powerful technical momentum that has propelled the stock well above its key moving averages.
Read full news article
Gayatri BioOrganics Ltd is Rated Sell
2026-04-28 10:10:03Gayatri BioOrganics Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 05 May 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 28 April 2026, providing investors with an up-to-date view of its fundamentals, returns, and market standing.
Read full news article
Gayatri BioOrganics Ltd is Rated Sell
2026-04-17 10:10:03Gayatri BioOrganics Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 05 May 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 17 April 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook.
Read full news article
Gayatri BioOrganics Ltd is Rated Sell
2026-04-06 10:10:28Gayatri BioOrganics Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 05 May 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 06 April 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.
Read full news article
Gayatri BioOrganics Ltd is Rated Sell
2026-03-26 10:10:02Gayatri BioOrganics Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 05 May 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 26 March 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.
Read full news article
Gayatri BioOrganics Ltd is Rated Sell
2026-03-15 10:10:02Gayatri BioOrganics Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 05 May 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 15 March 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.
Read full news article
Gayatri BioOrganics Ltd is Rated Sell by MarketsMOJO
2026-03-03 10:10:34Gayatri BioOrganics Ltd is rated 'Sell' by MarketsMOJO. This rating was last updated on 05 May 2025, but the analysis below reflects the stock's current position as of 03 March 2026, incorporating the latest fundamentals, returns, and financial metrics.
Read full news article
Gayatri BioOrganics Ltd is Rated Sell
2026-02-20 10:10:34Gayatri BioOrganics Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 05 May 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 20 February 2026, providing investors with an up-to-date perspective on the stock’s fundamentals, valuation, financial trends, and technical outlook.
Read full news articleAre Gayatri BioOrganics Ltd latest results good or bad?
2026-02-10 19:21:08Gayatri BioOrganics Ltd's latest financial results indicate a troubling situation for the company. The firm has reported zero net sales for the seventh consecutive quarter, reflecting a complete operational shutdown since June 2024. In the most recent quarter, Q3 FY26, the company incurred a net loss of ₹0.22 crores, which is a marginal increase from the previous quarter's loss of ₹0.21 crores. This trend of mounting losses is compounded by a negative shareholder equity of ₹35.89 crores and a negative book value of ₹4.56 per share, highlighting severe financial distress. The data reveals that the company's operating margin remains at 0.0%, consistent with its lack of operational activity. Employee costs and interest expenses persist despite the absence of revenue, indicating ongoing financial obligations that further strain the company's resources. The accumulated losses for the nine-month period of FY2026...
Read full news articleFormat of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2
01-May-2026 | Source : BSEFormat of the Annual Disclosure to be made by an entity identified as a Large Corporate.
| Sr. No. | Particulars | Details |
| 1 | Name of Company | Gayatri BioOrganics Ltd |
| 2 | CIN NO. | L24110TG1991PLC013512 |
| 3 | Report filed for FY | 2025-2026 |
| Details of the Current block (all figures in Rs crore): | ||
| 4 | 2 - year block period (Specify financial years)* | FY 2025-26 2026-27 |
| 5 | Incremental borrowing done in FY (T)(a) | 0.00 |
| 6 | Mandatory borrowing to be done through debt securities in FY (T) (b) = (25% of a) | 0.00 |
| 7 | Actual borrowing done through debt securities in FY (T)(c) | 0.00 |
| 8 | Shortfall in the borrowing through debt securities if any for FY (T - 1) carried forward to FY (T) (d) | 0 |
| 8 | Quantum of (d) which has been met from (c)(e)* | 0 |
| 9 | Shortfall if any in the mandatory borrowing through debt securities for FY (T) { after adjusting for any shortfall in borrowing for FY(T - 1) which was carried forward to FY(T)}(f) = (b) - [(c) - (e)]{ If the calculated value is zero or negative write nil}* | 0 |
| Details of penalty to be paid if any in respect to previous block (all figures in Rs crore): | |
| 2 - year Block period (Specify financial years) | FY 2024-25 2025-26 |
| Amount of fine to be paid for the block if applicable Fine = 0.2% of {(d) - (e)}# | 0.00 |
| Name of the Company Secretary :- | Huda Khan |
| Designation :- | Company Secretary and Compliance Officer |
| Name of the Chief Financial Officer :- | Achanta Prabhakar Rao |
| Designation : - | CFO |
Date: 01/05/2026
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
30-Apr-2026 | Source : BSEFormat of Initial Disclosure to be made by an entity identified as a Large Corporate.
| Sr. No. | Particulars | Details |
| 1 | Name of Company | Gayatri BioOrganics Ltd |
| 2 | CIN NO. | L24110TG1991PLC013512 |
| 3 | Outstanding borrowing of company as on 31st March / 31st December as applicable (in Rs cr) | 2.07 |
| 4 | Highest Credit Rating during the previous FY | NA |
| 4a | Name of the Credit Rating Agency issuing the Credit Rating mentioned in (4) | Not Applicable |
| 5 | Name of Stock Exchange# in which the fine shall be paid in case of shortfall in the required borrowing under the framework | BSE |
Designation: Company Secretary and Compliance Officer
EmailId: info@gayatribioorganics.com
Designation: CFO
EmailId: info@gayatribioorganics.com
Date: 30/04/2026
Note: In terms para of 3.2(ii) of the circular beginning F.Y 2022 in the event of shortfall in the mandatory borrowing through debt securities a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore an entity identified as LC shall provide in its initial disclosure for a financial year the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
11-Apr-2026 | Source : BSECertificate under Reg. 74 (5) of SEBI (DP) Regulations2018.
Corporate Actions
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available






